A hallmark of Alzheimer's is the accumulation of beta-amyloid protein in the brain, which is linked to cell death ...

The GE HealthCare imaging tool is coming out as pharma companies release new therapies onto the market to help treat the ...

There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...

The scientists looked at two brain scans and found that areas with more amyloid-beta showed increased brain activity, with ...

The failure to diagnose Alzheimer's disease—the most common form of dementia in the elderly—at an early stage of molecular ...

scan originally designed for diagnosing brain tumours and apply it to dementia diagnosis. This could help speed up diagnosis of Alzheimer’s disease and could also improve access to scanning methods ...

A study published Wednesday in Nature Neuroscience sheds light into how amyloid-beta and tau proteins impact brain activity ...

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...

Amyloid-beta and tau proteins have long been associated with Alzheimer's disease. The pathological buildup of these proteins ...

GE HealthCare’s recently acquired MIM Software division has secured an FDA clearance for a tool to help quantify the density ...

Alzheimer’s disease, a type of dementia that profoundly ... which can collect between neurons and block cell functions in the brain. A PET scan is a medical imaging technique that uses a small ...